The IVW method indicated that genetically predicted CD24+ CD27+ B cells were associated with a decreased risk of BC (OR = 0.9978, 95% CI: 0.996–0.999, p = 0.001, Figures 2A, B). This evidence concerns the gene CD27 and breast cancer.